RecruitingNCT07614906

Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage

Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage (SAH): a Prospective Observational Study

Sponsor

Massachusetts General Hospital

Enrollment

40 participants

Start Date

Mar 3, 2024

Study Type

OBSERVATIONAL

Conditions

Cerebral Vasospasm Aneurysmal Subarachnoid Hemorrhage

Summary

The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non-SAH patients. NO consumption levels will be analyzed from samples of participants' cerebral spinal fluid (CSF).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with aneurysmal subarachnoid hemorrhage and cerebral vasospasm. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.